Related Experiment Video
Updated: Jun 8, 2025
07:49
Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
114
A Call for Innovative Translational and Clinical Research to Address China's Unique Cancer Landscape
Chaoqi Zhang1, Peng Wu1, Dongyu Li1
1Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Cancer Discovery
|November 1, 2024
Summary
China
Area of Science:
- Oncology
- Pharmaceutical Development
- Regulatory Policy
Background:
- China's government has enacted policies to accelerate cancer drug development and clinical trials.
- Domestic pharmaceutical companies benefit from these initiatives, enhancing R&D pipelines.
- China presents unique challenges in cancer care due to prevalent cancer types and disease burdens often missed by global firms.
Purpose of the Study:
- To highlight the critical need for China-specific cancer care solutions.
- To emphasize the importance of advancing innovative pharmaceutical and clinical research within China.
- To focus on developing treatments for tumors disproportionately affecting the Chinese population.
Main Methods:
- Policy analysis of administrative laws and regulatory measures.
- Review of R&D pipelines and clinical trial advancements.
- Assessment of cancer prevalence and disease burden in China.
Main Results:
- Government policies have stimulated domestic cancer therapeutic development.
- Significant unmet needs exist for cancer treatments tailored to China's population.
- International pharmaceutical companies may overlook prevalent Chinese cancer types.
Conclusions:
- Promoting innovative pharmaceutical and clinical research is vital for China.
- Addressing China-specific cancer burdens requires focused development efforts.
- Tailored cancer therapies are crucial to meet the substantial unmet needs in China.
Related Concept Videos
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:43Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
01:30Cancer Vaccines
341
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
341
01:21Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K